Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting 2022-04-01 23:45
Zhongze Therapeutics Announces Successful Completion Of The First-In-Human Dose Escalation Study of ZZ6398 in Healthy Volunteers 2022-04-01 16:55
Akeso Reported 2021 Annual Results 2022-04-01 13:44
Zhimeng Biopharma Announces Dosing of First Subject in First-in-Human Phase -- Clinical Trial of CB06 2022-03-31 23:40
Aceemzyme Co., Ltd., challenging to new drug of brain diseases with recombinase-based ginsenoside Rh2 (s) mass production technology… 2022-03-31 21:00
I-Mab Announces Voluntary Lock-ups by Key Shareholders and Senior Management for Long-Term Commitment 2022-03-31 20:00
Brii Bio Presents New Data on BRII-835 (VIR-2218) in Chinese Patients with Chronic Hepatitis B at APASL 2022 2022-03-31 18:05
Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17) 2022-03-31 18:00
Airway Therapeutics Announces First Patient Dosed in Phase 1b Trial of AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD) 2022-03-31 17:00
JW Therapeutics Announces IND Approval for the Pivotal Clinical Trial of Carteyva® in Second-line Large B-Cell Lymphoma 2022-03-31 12:20
CStone announces first patient enrollment in the U.S. in the Phase 1 clinical trial of CS5001, a potential global best-in-class ROR1-targeting ADC 2022-03-31 08:02
Everest Medicines Submits New Drug Application in Hong Kong for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer 2022-03-31 08:00
LifeTech Scientific Corporation（1302.HK） Announces 2021 Annual Results 2022-03-31 03:27
Transcenta Announces Presentation of Preclinical Data of TST005 at the 2022 American Association for Cancer Research (AACR) Annual Meeting 2022-03-30 19:28
BioVaxys Expands Cancer Vaccine Platform 2022-03-30 16:02
First Year of Commercialization, Alphamab Oncology Reports Full Year 2021 Financial Results and Business Highlights 2022-03-30 10:36
First Year of Commercialization, Alphamab Oncology Reports Full Year 2021 Financial Results and Business Highlights 2022-03-30 10:35
RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines 2022-03-30 08:31
Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China 2022-03-30 08:05
Innovent Announced 2021 Annual Results 2022-03-30 08:00
1 193 194 195 196 197 423